VANESSA CANDARE: Open Payments
NPI 1134680564 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 11 payments from 9 companies in 2025. Trend: 2023 $253 · 2024 $777 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 3 | $160 |
| PFIZER INC. | 1 | $92 |
| GENZYME CORPORATION | 1 | $34 |
| Incyte Corporation | 1 | $32 |
| Chiesi USA, Inc. | 1 | $30 |
| Krystal Biotech Inc | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $22 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
Products named: Zoryve, LITFULO, DUPIXENT, OPZELURA, FILSUVEZ, VYJUVEK, RINVOQ, HEMANGEOL.
Industry payments across CA — which companies pay providers there.
